↓ Skip to main content

Combination of CTLA-4 and PD-1 blockers for treatment of cancer

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, June 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

blogs
1 blog
twitter
14 X users
patent
7 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
612 Dimensions

Readers on

mendeley
598 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Published in
Journal of Experimental & Clinical Cancer Research, June 2019
DOI 10.1186/s13046-019-1259-z
Pubmed ID
Authors

Anand Rotte

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 598 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 598 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 89 15%
Student > Ph. D. Student 70 12%
Student > Master 69 12%
Researcher 52 9%
Other 26 4%
Other 68 11%
Unknown 224 37%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 119 20%
Medicine and Dentistry 82 14%
Immunology and Microbiology 47 8%
Pharmacology, Toxicology and Pharmaceutical Science 28 5%
Agricultural and Biological Sciences 25 4%
Other 53 9%
Unknown 244 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2023.
All research outputs
#1,838,006
of 25,402,889 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#62
of 2,386 outputs
Outputs of similar age
#39,369
of 368,356 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#4
of 86 outputs
Altmetric has tracked 25,402,889 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,386 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,356 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.